Results 191 to 200 of about 2,444,315 (286)
Transforming stroke care: the promise of feedback-guided thrombolytic nanomedicine. [PDF]
Wang Y +6 more
europepmc +1 more source
ECM, extracellular matrix; BDNF, brain‐derived neuroptrophic factor; FGF, fibroblast growth factor; VEGF, vascular endothelial growth factor. Abstract Heparan sulfate, a structurally diverse glycosaminoglycan that is abundant in the central nervous system (CNS), orchestrates essential processes fundamental to neural plasticity, neurorepair, and ...
Mozammel H. Bhuiyan +3 more
wiley +1 more source
Magnetic particle clusters with tunable thrombus penetration for enhanced thrombolysis. [PDF]
Lei Y +7 more
europepmc +1 more source
Evolution of advanced revascularization strategies for high-risk pulmonary embolism: a physiology-guided single-center experience. [PDF]
Greenspon LW +4 more
europepmc +1 more source
Immunomodulatory Nanozymes as Programmable Redox–Immune Set‐Point Regulators
Conceptual phase space linking reactive oxygen species level/dynamics to immune state, with pathological set‐points for chronic inflammation, tumor escape, and degeneration contrasted against a central healthy redox–immune set‐point. Buffering and amplifying nanozymes are depicted as devices that dial redox tone up or down to steer diseased ...
Sumi Choi +3 more
wiley +1 more source
Perioperative severe airway hemorrhage during veno-arterial extracorporeal membrane oxygenation for acute massive pulmonary embolism: A case report. [PDF]
Cao K, Hai F.
europepmc +1 more source
Acute intrapartum deep venous thrombosis: A case report
International Journal of Gynecology &Obstetrics, Volume 174, Issue 3, Page 1680-1682, September 2026.
Faith Arimoro +2 more
wiley +1 more source
Reduced right ventricular global longitudinal strain (RVGLS) was associated with increased 30‐day mortality in an external cohort of patients with intermediate‐risk pulmonary embolism. RVGLS demonstrated discriminative ability (AUC 0.802), and the previously established 17.7% cutoff was associated with differences in 30‐day survival, supporting its ...
Shunsuke Eguchi +7 more
wiley +1 more source

